Clinical Trials Browser

Phase 2 × Not yet recruiting × Waldenstrom Macroglobulinemia × Clear all

NCT07464210 2026-03-11

Nemtabrutinib, Bortezomib, and Rituximab for WM

Phase 2 Not yet recruiting

Waldenstrom Macroglobulinemia

NCT07259122 2025-12-02

ZBR in WM

Phase 2 Not yet recruiting

Waldenstrom Macroglobulinemia

NCT06547866 2025-11-26

WAZABI

Phase 2 Not yet recruiting

Waldenstrom Macroglobulinemia